Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Protara Therapeutics Profit Margin 2013-2023 | TARA

Current and historical gross margin, operating margin and net profit margin for Protara Therapeutics (TARA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Protara Therapeutics net profit margin as of December 31, 2023 is 0%.
  
Protara Therapeutics Annual Profit Margins
Protara Therapeutics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.033B $0.000B
Protara Therapeutics Inc. is committed to identifying and advancing transformative therapies for rare and specialty diseases. The company's portfolio includes, TARA-002, an investigational cell therapy being developed for the treatment of lymphatic malformations, and intravenous Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. Protara Therapeutics Inc., formerly known as ArTara Therapeutics, is based in NEW YORK, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $72.455B 29.78
Chugai Pharmaceutical (CHGCY) Japan $50.600B 22.62
Takeda Pharmaceutical (TAK) Japan $41.238B 6.68
Merck (MKGAF) Germany $20.301B 19.16
Astellas Pharma (ALPMY) Japan $17.282B 27.29
Shionogi (SGIOY) Japan $14.324B 12.39
Sandoz Group AG (SDZNY) Switzerland $14.137B 0.00
Neurocrine Biosciences (NBIX) United States $13.532B 56.19
United Therapeutics (UTHR) United States $11.005B 11.79
Catalent (CTLT) United States $10.120B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.712B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.896B 6.99
Ionis Pharmaceuticals (IONS) United States $6.062B 0.00
Revolution Medicines (RVMD) United States $5.922B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.232B 0.00
Madrigal Pharmaceuticals (MDGL) United States $3.847B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.932B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.741B 0.00
Summit Therapeutics (SMMT) United States $2.709B 0.00
Indivior (INDV) United States $2.424B 11.49
Corcept Therapeutics (CORT) United States $2.373B 24.00
PTC Therapeutics (PTCT) United States $2.189B 0.00
Dyne Therapeutics (DYN) United States $2.131B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.963B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.905B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.802B 10.67
Evotec AG (EVO) Germany $1.779B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.757B 18.16
Avadel Pharmaceuticals (AVDL) Ireland $1.613B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 27.89
Ardelyx (ARDX) United States $1.494B 0.00
Soleno Therapeutics (SLNO) United States $1.266B 0.00
Xencor (XNCR) United States $1.232B 0.00
Pacira BioSciences (PCRX) United States $1.225B 12.19
Ironwood Pharmaceuticals (IRWD) United States $1.224B 11.50
Collegium Pharmaceutical (COLL) United States $1.191B 7.33
4D Molecular Therapeutics (FDMT) United States $1.189B 0.00
Cronos Group (CRON) Canada $0.989B 0.00
Cassava Sciences (SAVA) United States $0.966B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.895B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.858B 0.00
Relay Therapeutics (RLAY) United States $0.843B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Sage Therapeutics (SAGE) United States $0.824B 0.00
ARS Pharmaceuticals (SPRY) United States $0.806B 0.00
Enliven Therapeutics (ELVN) United States $0.804B 0.00
Ocular Therapeutix (OCUL) United States $0.734B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.710B 0.00
Silence Therapeutics (SLN) United Kingdom $0.647B 0.00
Siga Technologies (SIGA) United States $0.625B 9.25
Savara (SVRA) United States $0.609B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.581B 0.00
Lyell Immunopharma (LYEL) United States $0.553B 0.00
OmniAb (OABI) United States $0.525B 0.00
Verve Therapeutics (VERV) United States $0.515B 0.00
Altimmune (ALT) United States $0.515B 0.00
Korro Bio (KRRO) United States $0.505B 0.00
Exscientia (EXAI) United Kingdom $0.487B 0.00
ProKidney (PROK) United States $0.486B 0.00
KalVista Pharmaceuticals (KALV) United States $0.455B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.443B 0.00
Lexeo Therapeutics (LXEO) United States $0.412B 0.00
Larimar Therapeutics (LRMR) United States $0.411B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Harrow (HROW) United States $0.372B 0.00
Heron Therapeutics (HRTX) United States $0.368B 0.00
Nature's Sunshine Products (NATR) United States $0.367B 20.53
Corbus Pharmaceuticals Holdings (CRBP) United States $0.360B 0.00
Esperion Therapeutics (ESPR) United States $0.360B 0.00
Fractyl Health (GUTS) United States $0.321B 0.00
Bioventus (BVS) United States $0.315B 0.00
Organogenesis (ORGO) United States $0.310B 58.75
Black Diamond Therapeutics (BDTX) United States $0.309B 0.00
Aquestive Therapeutics (AQST) United States $0.298B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Metagenomi (MGX) United States $0.282B 0.00
Lyra Therapeutics (LYRA) United States $0.282B 0.00
Akebia Therapeutics (AKBA) United States $0.281B 0.00
Nanobiotix S.A (NBTX) France $0.271B 0.00
ESSA Pharma (EPIX) Canada $0.269B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.259B 0.00
Pyxis Oncology (PYXS) United States $0.250B 0.00
Adherex Technologies (FENC) United States $0.250B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Foghorn Therapeutics (FHTX) United States $0.234B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Conduit Pharmaceuticals (CDT) United States $0.231B 0.00
Prelude Therapeutics (PRLD) United States $0.224B 0.00
Avita Medical (RCEL) United States $0.220B 0.00
Galectin Therapeutics (GALT) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Telomir Pharmaceuticals (TELO) United States $0.203B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.193B 0.00
Acrivon Therapeutics (ACRV) United States $0.192B 0.00
Century Therapeutics (IPSC) United States $0.187B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Regulus Therapeutics (RGLS) United States $0.158B 0.00
Achieve Life Sciences (ACHV) Canada $0.158B 0.00
CytoDyn (CYDY) United States $0.142B 0.00
Elite Pharmaceuticals (ELTP) United States $0.142B 13.25
Incannex Healthcare (IXHL) Australia $0.141B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Karyopharm Therapeutics (KPTI) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.120B 2.51
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Eliem Therapeutics (ELYM) United States $0.110B 0.00
Citius Pharmaceuticals (CTXR) United States $0.106B 0.00
GlycoMimetics (GLYC) United States $0.106B 0.00
Inotiv (NOTV) United States $0.104B 0.00
FibroGen (FGEN) United States $0.103B 0.00
OptiNose (OPTN) United States $0.097B 0.00
AlloVir (ALVR) United States $0.092B 0.00
PMV Pharmaceuticals (PMVP) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
ProPhase Labs (PRPH) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.079B 6.37
Tempest Therapeutics (TPST) United States $0.079B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.87
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Jaguar Animal Health (JAGX) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
JanOne (JAN) United States $0.044B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.032B 0.00
DURECT (DRRX) United States $0.029B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Nutriband (NTRB) United States $0.028B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.025B 11.73
PolyPid (PYPD) Israel $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Addex Therapeutics (ADXN) Switzerland $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Avalo Therapeutics (AVTX) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
SHINECO (SISI) China $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.24
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.42